These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 84045)

  • 21. A suppressor T cell of the mixed lymphocyte reaction specific for the HLA-D region in man.
    Engleman EG; McDevitt HO
    J Clin Invest; 1978 Mar; 61(3):828-38. PubMed ID: 147885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recognition by xenogeneic cytotoxic T lymphocytes of cells expressing HLA-A2 or HLA-B7 after DNA-mediated gene transfer.
    Herman A; Parham P; Weissman SM; Engelhard VH
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5056-60. PubMed ID: 6192447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA public determinants are target antigens of cell-mediated cytotoxicity.
    Schwartz BD; Luehrman LK; Rodey GE
    J Exp Med; 1980 Aug; 152(2 Pt 2):340s-350s. PubMed ID: 6157769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated lympholysis: target susceptibility to lysis correlates with surface major histocompatibility complex expression.
    Suranyi MG; Waugh J; Bishop GA; Hall BM
    Transplant Proc; 1987 Feb; 19(1 Pt 1):417-20. PubMed ID: 2950620
    [No Abstract]   [Full Text] [Related]  

  • 25. Human Ia-like antigens associated with HLA-d.
    Albrechtsen D; Solheim BG; Thorsby E
    Scand J Immunol; 1977; 6(5):419-25. PubMed ID: 70059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA regulates postrenal transplant CML nonreactivity.
    Goulmy E; Blokland E; Persijn G; Paul LC; Wilmink J; van Rood JJ
    J Immunol; 1985 Nov; 135(5):3082-6. PubMed ID: 3900203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The human major histocompatibility complex or HLA complex].
    Lemonnier FA
    Biochimie; 1985 Jan; 67(1):XI-XV. PubMed ID: 2581625
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple epitopes on human and murine cells expressing HLA-B7 as defined by specific murine cytotoxic T cell clones.
    Yannelli JR; Moore LC; Engelhard VH
    J Immunol; 1985 Aug; 135(2):900-5. PubMed ID: 2409157
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of human lymphocytes primed against allogeneic cells in vitro. 1. Optimalization of culture conditions for detection of HLA--D specificity.
    Moen T; Thorsby E
    Tissue Antigens; 1978 Nov; 12(5):367-80. PubMed ID: 85352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential behavior of cytotoxic effector cells against HLA antigens in strong genetic linkage disequilibrium.
    Kim SJ; Christiansen FT; Silver DM; Dupont B
    Immunogenetics; 1981; 13(4):297-309. PubMed ID: 6168580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA restriction of non-HLA--A, --B, --C and --D cell mediated lympholysis (CML).
    Goulmy E; Termijtelen A; Bradley BA; van Rood JJ
    Tissue Antigens; 1976 Nov; 8(5):317-26. PubMed ID: 65023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxic T lymphocytes directed against HLA-Bw 35-linked target determinants show differences in sensitivity toward antibiotics during sensitization period.
    Horai S; Goulmy E; van Rood JJ
    Hum Immunol; 1982 Jul; 4(4):335-41. PubMed ID: 6981634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human cytotoxic T cell responses to trinitrophenyl hapten and influenza virus. Diversity of restriction antigens and specificity of HLA-linked genetic regulation.
    Biddison WE; Payne SM; Shearer GM; Shaw S
    J Exp Med; 1980 Aug; 152(2 Pt 2):204s-217s. PubMed ID: 6157766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of human T lymphocyte subsets: helper and suppressor/cytotoxic T cells recognize and respond to distinct histocompatibility antigens.
    Engleman EG; Benike CJ; Grumet FC; Evans RL
    J Immunol; 1981 Nov; 127(5):2124-9. PubMed ID: 6457863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of human CML target. HLA-B locus (B12) antigen variants defined by CTL generated between B locus-identical (B12) responder-stimulator pairs.
    Kato S; Iványi P; Lacko E; Breur B; Du Bois R; Eijsvoogel VP
    J Immunol; 1982 Feb; 128(2):949-55. PubMed ID: 6976390
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of a polymorphic monocyte antigen in HLA.
    van Leeuwen A; Termijtelen A; Shaw S; van Rood JJ
    Nature; 1982 Aug; 298(5874):565-7. PubMed ID: 6980374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The genetics of cell-mediated lympholysis.
    Long MA; Handwerger BS; Amos DB; Yunis EJ
    J Immunol; 1976 Dec; 117(6):2092-9. PubMed ID: 62806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spontaneous cell-mediated cytotoxicity and generation of HLA-unrelated cytotoxic effector cells during MLC in vitro.
    Leibold W; Gatti RA; Just S; Peter HH
    Transplant Proc; 1979 Jun; 11(2):1393-9. PubMed ID: 157578
    [No Abstract]   [Full Text] [Related]  

  • 40. The characteristics of the HLA antigens determined by cellular techniques.
    Buc M; Stefanovic J
    Allerg Immunol (Leipz); 1986; 32(1):19-25. PubMed ID: 2424294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.